OnePath Co-Pay Assistance Program
The OnePath Co-Pay Assistance Program helps cover certain out-of-pocket treatment costs for eligible, commercially insured patients who are enrolled in OnePath.
The following are covered up to the program maximum and may be paid directly to the provider*:
- 100% coverage of eligible out-of-pocket costs, which may include deductibles, co-pays, and co-insurance†
Out-of-pocket cost of eligible injection charges where applicable by law
At a minimum, to be eligible for the program, a patient must:
- Be enrolled in OnePath
- Have commercial insurance
Other eligibility requirements apply. For more information, please contact a OnePath Patient Support Manager at 1-866-888-0660.
*IMPORTANT NOTICE: The OnePath Co-Pay Assistance Program (the Program) is not valid for prescriptions eligible to be reimbursed, in whole or in part, by Medicaid, Medicare (including Medicare Part D), Tricare, Medigap, VA, DoD, or other federal or state programs (including any medical or state prescription drug assistance programs). No claim for reimbursement of the out-of-pocket expense amount covered by the Program shall be submitted to any third-party payer, whether public or private. The Program cannot be combined with any other rebate/coupon, free trial, or similar offer. Co-payment assistance under the Program is not transferable. The Program only applies in the United States, including Puerto Rico and other U.S. territories, and does not apply where prohibited by law, taxed, or restricted. This does not constitute health insurance. Void where use in prohibited by your insurance provider. If your insurance situation changes you must notify the Program immediately at 1-866-888-0660. Coverage of certain administration charges does not apply for patients residing in Massachusetts, Michigan, Minnesota, Rhode Island, and Vermont. Takeda reserves the right to rescind, revoke, or amend the Program at any time without notice.
KALBITOR Home Infusion Services
The KALBITOR Home Infusion Services® program provides nurse home visits to administer treatment to eligible patients:
- An initial clinical consultation includes patient education related to the infusion services and review of product label and information
Nurses will then visit as necessary and administer KALBITOR® (ecallantide) as prescribed
- Nurses are trained to treat a hypersensitivity reaction should one occur
- Patients will be directed to the closest emergency facility for life-threatening HAE attacks including, but not limited to, throat (laryngeal) attacks